Home  /  Resource Library  /  Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphoma

Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphoma

Results of a study examining brentuximab vedotin and nivolumab combined with chemotherapy for treatment of Hodgkin lymphoma.